Literature DB >> 18473843

AGE-RAGE system and carcinogenesis.

Riichiro Abe1, Sho-ichi Yamagishi.   

Abstract

Recent clinical studies have reported an increased risk for various types of cancers in patients with diabetes. Diabetes is characterized by increased oxidative stress conditions. Hyperglycemia induces oxidative stress generation in a variety of cells via various metabolic pathways, thus causing oxidative DNA damage, an initial step of carcinogenesis. There is accumulating evidence that advanced glycation end products (AGE), senescent macroprotein derivatives formed at an accelerated rate under normal aging process and diabetes, are involved in the development and progression of cancers. AGE stimulate oxidative stress generation through the interaction with a receptor for AGE (RAGE), while oxidative stress generation promotes the formation of AGE and increases the expression of RAGE. These findings suggest that the crosstalk between the AGE-RAGE system and oxidative stress generation may form a positive feedback loop, thus further increasing the risk for cancers in patients with diabetes. This paper reviews current knowledge about the role of AGE-RAGE system in the development of various types of cancers.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18473843     DOI: 10.2174/138161208784139765

Source DB:  PubMed          Journal:  Curr Pharm Des        ISSN: 1381-6128            Impact factor:   3.116


  60 in total

1.  MK615 decreases RAGE expression and inhibits TAGE-induced proliferation in hepatocellular carcinoma cells.

Authors:  Yuhki Sakuraoka; Tokihiko Sawada; Toshie Okada; Takayuki Shiraki; Yoshikazu Miura; Katsuya Hiraishi; Tatsushi Ohsawa; Masakazu Adachi; Jun-ichi Takino; Masayoshi Takeuchi; Keiichi Kubota
Journal:  World J Gastroenterol       Date:  2010-11-14       Impact factor: 5.742

2.  AGE/RAGE/Akt pathway contributes to prostate cancer cell proliferation by promoting Rb phosphorylation and degradation.

Authors:  Ji-Ming Bao; Min-Yi He; Ya-Wei Liu; Yong-Jie Lu; Ying-Qia Hong; Hai-Hua Luo; Zhong-Lu Ren; Shan-Chao Zhao; Yong Jiang
Journal:  Am J Cancer Res       Date:  2015-04-15       Impact factor: 6.166

3.  Elevation of Serum Levels of Advanced Glycation End Products in Patients With Non-B or Non-C Hepatocellular Carcinoma.

Authors:  Hiromi Kan; Sho-ichi Yamagishi; Ayako Ojima; Kei Fukami; Seiji Ueda; Masayoshi Takeuchi; Hideyuki Hyogo; Hiroshi Aikata; Kazuaki Chayama
Journal:  J Clin Lab Anal       Date:  2014-09-23       Impact factor: 2.352

Review 4.  Contribution of the toxic advanced glycation end-products-receptor axis in nonalcoholic steatohepatitis-related hepatocellular carcinoma.

Authors:  Jun-Ichi Takino; Kentaro Nagamine; Takamitsu Hori; Akiko Sakasai-Sakai; Masayoshi Takeuchi
Journal:  World J Hepatol       Date:  2015-10-18

5.  Clinical benefits of metformin in gynecologic oncology.

Authors:  Atsushi Imai; Satoshi Ichigo; Kazutoshi Matsunami; Hiroshi Takagi; Keigo Yasuda
Journal:  Oncol Lett       Date:  2015-05-25       Impact factor: 2.967

6.  Targeting of RAGE-ligand signaling impairs breast cancer cell invasion and metastasis.

Authors:  T Kwak; K Drews-Elger; A Ergonul; P C Miller; A Braley; G H Hwang; D Zhao; A Besser; Y Yamamoto; H Yamamoto; D El-Ashry; J M Slingerland; M E Lippman; B I Hudson
Journal:  Oncogene       Date:  2016-09-26       Impact factor: 9.867

7.  Soluble receptor for advanced glycation end products and risk of liver cancer.

Authors:  Kristin A Moy; Li Jiao; Neal D Freedman; Stephanie J Weinstein; Rashmi Sinha; Jarmo Virtamo; Demetrius Albanes; Rachael Z Stolzenberg-Solomon
Journal:  Hepatology       Date:  2013-05-14       Impact factor: 17.425

8.  Sugars and risk of mortality in the NIH-AARP Diet and Health Study.

Authors:  Natasha Tasevska; Yikyung Park; Li Jiao; Albert Hollenbeck; Amy F Subar; Nancy Potischman
Journal:  Am J Clin Nutr       Date:  2014-02-19       Impact factor: 7.045

9.  RAGE-aptamer Attenuates the Growth and Liver Metastasis of Malignant Melanoma in Nude Mice.

Authors:  Nobutaka Nakamura; Takanori Matsui; Yuji Ishibashi; Ami Sotokawauchi; Kei Fukami; Yuichiro Higashimoto; Sho-Ichi Yamagishi
Journal:  Mol Med       Date:  2017-11-06       Impact factor: 6.354

10.  The receptor RAGE: Bridging inflammation and cancer.

Authors:  Astrid Riehl; Julia Németh; Peter Angel; Jochen Hess
Journal:  Cell Commun Signal       Date:  2009-05-08       Impact factor: 5.712

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.